TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers.
Nat Med. 2021 Mar;27(3):419-425. doi: 10.1038/s41591-020-01225-1. Epub 2021 Feb 8.
Nat Med. 2021.
PMID: 33558725